Simulations Plus CEO granted 50,000 options at $16.02 (Form 4)
Simulations Plus (SLP) reported an insider equity grant: Chief Executive Officer Shawn O’Connor received 50,000 stock options to purchase common stock at an exercise price of $16.02 per share on 10/16/2025.
Rhea-AI Filing Summary
Simulations Plus (SLP) reported an insider equity grant: Chief Executive Officer Shawn O’Connor received 50,000 stock options to purchase common stock at an exercise price of $16.02 per share on 10/16/2025. The options expire on 10/15/2035 and were reported as a direct holding following the transaction.
The award vests over three years: 40% on the first anniversary, then 30% on each of the second and third anniversaries. The filing reflects a routine compensation grant under which the number of derivative securities beneficially owned after the transaction is 50,000.
Positive
- None.
Negative
- None.
Insights
Routine CEO option grant with three-year vesting.
The CEO of Simulations Plus received 50,000 stock options with an exercise price of $16.02 on 10/16/2025, expiring 10/15/2035. The transaction code indicates an award, consistent with standard executive compensation practices.
Vesting is time-based: 40% after one year, then 30% in each of the next two years, aligning incentives over a three-year period. The form shows 50,000 derivative securities beneficially owned after the grant.
This is an administrative disclosure rather than a directional event. Any impact depends on future stock performance and exercise decisions, which are not addressed in the excerpt.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 50,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The stock options shall vest 40% on the first anniversary date and continuing to vest on the 2nd and 3rd anniversary dates thereafter at 30%.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did SLP disclose in this Form 4?
What is the vesting schedule for the SLP CEO’s option grant?
When do the granted options expire for SLP’s CEO?
How many derivative securities are beneficially owned after the reported transaction?
What security type was granted to the SLP CEO?
Was the ownership reported as direct or indirect?
What is the exercise price of the options granted to SLP’s CEO?
AI-generated analysis. How Rhea-AI works. Not financial advice.